Info/Guidance for Health Care Providers
Guidance and information for various health care settings and services from the N.C. Department of Health and Human Services.
Can't find what you're looking for? Search the CDC's COVID-19 website.
General Guidance
Accessibility
- Accessibility Tips, Tricks and FAQs (Spanish)
- Advancing Equity through Language, Communication and Physical Access (Spanish)
- Accessibility at Drive-Thru Medical Sites
- Historically Marginalized Populations Engagement Toolkit
- Americans with Disabilities Act (ADA) and Section 504 Rehabilitation Act (RA) Protections during COVID-19
For Providers with Deaf, Hard of Hearing and DeafBlind Patients
Behavioral Health
- Resources: COVID-19 and Behavioral Health
- Strategies for Counties to Support Behavior Health and IDD Services
- COVID Letter to LME-MCOs
- NCDHHS Outpatient and Crisis System Providers
- NCDHHS Behavioral Health/IDD Day Program and Facility-Based Crisis Guidance (June 10, 2020)
- NC Innovations and TBI Waiver Appendix K FAQs (May 6, 2020)
- CDC Guidance for Direct Service Providers
Infection Prevention Guidance
NCDHHS refers to CDC and CMS guidance:
- CDC Information for Healthcare Settings
- CDC - Managing HCP with SARS-CoV-2 Infection or Exposure
- CDC - Mitigating Staff Shortages
- CMS - QSO Nursing Home Visitation
Regional Infection Prevention Teams
- RIPS Team Program Overview
- Comprehensive RIPS ICAR
- Environmental Rounds Tool - for use in small family care/group homes
Pregnancy and Child Health
- Outpatient Assessment and Management for Pregnant Women
- ACOG Practice Advisory General Information Regarding Pregnant Individuals and COVID-19
- CDC Evaluation and Management Considerations for Neonates At Risk for COVID-19
- CDC Pediatric Healthcare Providers Caring for Children
- Multisystem Inflammatory Syndrome in Children (MIS-C)
General Guidance
- Testing Info for Partners and Providers
- Collecting COVID-19 Samples: Guidance for Non-Clinical Community Partners
- Request Specimen Collection Supplies
- Testing Surge Workgroup
- CDC Antigen Test Algorithm
- CDC - Healthcare Worker Guidance on COVID-19 Testing
- CDC - COVID-19 Data Tracker
(Go to Long-Term Care Facilities for setting-specific testing guidance)
Laboratories
Reporting
- 10A NCAC 41A .0107- Reporting of COVID-19 Test Results
- Federal Guidance for Reporting of COVID-19 Test Results
- NCDHHS Guidance for Reporting COVID-19 Diagnostic Test Results
- Provider Memo: Sequencing and Breakthrough Cases
- Antigen Results - Downloadable Excel Spreadsheet
Statewide Standing Orders for Testing
- Order for COVID-19 Diagnostic Testing (July 25, 2022)
- Order to Allow Pharmacists to Dispense Over the Counter At-Home COVID-19 Tests (Jan. 14, 2022)
Therapeutics
General Guidance
- Provider Hub
- One-Pager for Patients (Bilingual)
- NC Board of Pharmacy COVID-19 Updates and Resources
- CDC Considerations for Pharmacies During COVID-19
- Pet Industry Joint Advisory Council Statement on Off-Label Usage
- FDA Letter on Hydroxychloroquine
- Hydroxychloroquine Emergency Use Authorization (EUA) Fact Sheet for Health Care Providers
Statewide Standing Order Recissions for Therapeutics
- Intravenous Administration of Bebtelovimab Monoclonal Antibodies (Nov. 30, 2022)
- Intravenous Administration of Sotrovimab Monoclonal Antibodies (April 6, 2022)
- Subcutaneous Administration of Casirivimab/Imdevimab (REGEN-COV) Monoclonal Antibodies (Jan. 24, 2022)
- Intravenous Administration of Casirivimab/Imdevimab (REGEN-COV) Monoclonal Antibodies (Jan. 24, 2022)
- Intravenous Administration of Bamlanivimab/Etesevimab Monoclonal Antibodies (Jan. 24, 2022)
Vaccines
General Guidance
- How to Use the COVID-19 Vaccine Management System (CVMS)
- NCDHHS COVID-19 Vaccine Provider Guidance (July 29, 2022)
- CDC - COVID-19 Vaccination Planning and Partnerships
- Secretarial Order 8 (March 3, 2021) - Allows licensed dentists to administer COVID-19 vaccinations
- Coadministration of the COVID-19 Vaccine (Sept. 24, 2021)
Statewide Standing Orders for Vaccine Administration
Moderna Bivalent Vaccines
- Moderna Bivalent COVID-19 Vaccine for 6 Months-5 Years (April 21, 2023)
- Moderna Bivalent COVID-19 Vaccine for 6 Years and Older (May 8, 2023)
Pfizer Bivalent Vaccines
- Pfizer-BioNTech Bivalent COVID-19 Vaccine for 6 Months-4 Years (May 8, 2023)
- Pfizer-BioNTech Bivalent COVID-19 Vaccine for 5 Years and Older (April 21, 2023)
Novavax Vaccine
- Novavax COVID-19 Vaccine for 12 Years and Older (May 25, 2023)